apitegromab tirzepatide Menno A drug added to Zepbound

If patients receive GLP1 medications outside their primary health system (for example, from telehealth) or change providers during the treatment, the EHR data collected in our study may not capture the full course of treatment, and this may explain our observation of generally shorter treatment durations, and hence less weight loss, recorded in EHRs

16 In people with type 2 diabetes, over follow-up of 4050 weeks, tirzepatide 5 mg, 10 mg and 15 mg once weekly demonstrated: Superior HbA 1c reduction from baseline versus all comparators (see Table 1 )

Clinical Administration Standards And Injection Support Healthcare organizations continue to prioritize education surrounding safe medication delivery, particularly for first-time users

Egrifta SV is single-use and should be injected right after mixing per the label